These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 2846252)

  • 1. [Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].
    Schofer J
    Dtsch Med Wochenschr; 1988 Oct; 113(43):1684-9. PubMed ID: 2846252
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of angiotensin-converting enzyme inhibitors in congestive heart failure.
    Galvao M
    Heart Lung; 1990 Sep; 19(5 Pt 1):505-11. PubMed ID: 2211159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of angiotensin-converting enzyme inhibitors.
    Wyvratt MJ
    Clin Physiol Biochem; 1988; 6(3-4):217-29. PubMed ID: 2849521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiotensin-converting enzyme inhibitors in heart failure].
    Gullestad L; Søyland E; Dolva LO; Kjekshus J
    Tidsskr Nor Laegeforen; 1987 Sep; 107(25):2112-6. PubMed ID: 2823410
    [No Abstract]   [Full Text] [Related]  

  • 7. [Converting enzyme inhibitors in the treatment of chronic heart insufficiency: a meta-analysis of controlled clinical trials with placebo].
    de Abajo FJ; Lopo CR
    Med Clin (Barc); 1988 Sep; 91(7):249-55. PubMed ID: 2848164
    [No Abstract]   [Full Text] [Related]  

  • 8. A three year clinical review of the impact of angiotensin converting enzyme inhibitors on the intra hospital mortality of congestive heart failure in Nigerians.
    Adewole AD; Ikem RT; Adigun AQ; Akintomide AO; Balogun MO; Ajayi AA
    Cent Afr J Med; 1996 Aug; 42(8):253-5. PubMed ID: 8990572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotension after first-dose ACE inhibitor administration in heart failure--should doctors stop worrying?
    Remme WJ
    Cardiovasc Drugs Ther; 2001 Nov; 15(6):475-7. PubMed ID: 11916355
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
    Davie AP; Rumley A; Lowe GD; McMurray JJ
    Thromb Haemost; 2001 Dec; 86(6):1585-6. PubMed ID: 11776334
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in kidney function during treatment of heart failure patients with ACE inhibitors].
    Dietz R; Nagel F; Osterziel KJ
    Verh Dtsch Ges Inn Med; 1991; 97():545-8. PubMed ID: 1667051
    [No Abstract]   [Full Text] [Related]  

  • 12. [ACE inhibitors or AT1 receptor antagonists?].
    Riegger GA
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S37-9. PubMed ID: 10535045
    [No Abstract]   [Full Text] [Related]  

  • 13. Adaptive and maladaptive actions of angiotensin II in patients with severe congestive heart failure.
    Packer M
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):66-73. PubMed ID: 3037891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH
    Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiotensin-converting enzyme inhibitors in the treatment of heart failure: toward a change in the natural history of the disease].
    Martín Luengo C; Arribas Jiménez A; Nieto Ballestero F; Diego Domínguez M; Cascón Bueno M; Pabón Osuna P; Sala Sánchez-Castillo A
    Rev Esp Cardiol; 1993 Mar; 46(3):131-45. PubMed ID: 8488316
    [No Abstract]   [Full Text] [Related]  

  • 16. Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic.
    Packer M
    Int J Cardiol; 1985 Feb; 7(2):111-20. PubMed ID: 2982750
    [No Abstract]   [Full Text] [Related]  

  • 17. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C; Cosentino E; De Sanctis D
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiotensin-converting enzyme (ACE) inhibitors in cardiac decompensation; from randomized study to individual patient].
    van Vlies B
    Ned Tijdschr Geneeskd; 1992 Sep; 136(37):1796-8. PubMed ID: 1407135
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors: are there significant clinical differences?
    Jessup M
    J Am Coll Cardiol; 1989 May; 13(6):1248-50. PubMed ID: 2539404
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse effects of converting-enzyme inhibition in patients with severe congestive heart failure: pathophysiology and management.
    Packer M; Kessler PD; Gottlieb SS
    Postgrad Med J; 1986; 62 Suppl 1():179-82. PubMed ID: 3022272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.